In this live webinar, expert faculty will discuss practical application of optimal COVID-19 outpatient management, including rapid-fire cases with expert panel discussion.
1.25 AMA, ANCC, ACPE credits
Physicians, nurse practitioners, pharmacists, and other healthcare professionals involved in the management of patients with COVID-19, including both specialists and primary care providers. This identified target audience will benefit from this education by gaining the knowledge and strategies necessary to individualize early outpatient COVID-19 management.
Division of Palliative Medicine
RWJ Barnabas Health
New Brunswick, New Jersey
Immediate Past President
New Jersey State Society of Physician Assistants
Allentown, New Jersey
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Clinical Pharmacy Specialist in Infectious Diseases
Department of Pharmacy
Emory University Hospital Midtown
2023 Update: Practical Case Studies in Outpatient COVID-19 Management
There are no fees required to participate in this activity.
Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact email@example.com prior to the live event.
The goal of this activity is to improve healthcare professionals’ knowledge and competence and foster an interprofessional approach for early SARS-CoV-2 diagnosis and treatment in the outpatient setting to mitigate severe and long-term consequences of COVID-19.
This program is intended for physicians, nurse practitioners, pharmacists, and other healthcare professionals involved in the management of patients with COVID-19, including both specialists and primary care providers. This identified target audience will benefit from this education by gaining the knowledge and strategies necessary to individualize early outpatient COVID-19 management.
Upon completion of this activity, participants should be able to:
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO), ProCE, LLC, and Practicing Clinicians Exchange. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Designation of Credit
CCO designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.25 contact hours.
Continuing Pharmacy Education
CCO designates this continuing education activity for 1.25 contact hours (0.125 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-9999-23-061-L01-P
Type of Activity: Application
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO), ProCE, LLC, and Practicing Clinicians Exchange (PCE), require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO, ProCE, and PCE policy. CCO, ProCE, and PCE are committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Provided by Clinical Options, LLC, in partnership with Practicing Clinicians Exchange (PCE) and ProCE.
Supported by educational grants from Gilead Sciences, Inc. and Merck Sharp & Dohme Corp.